Boehringer Ingelheim CEO: Pharma needs bright minds

Shashank Deshpande, CEO of Boehringer Ingelheim since July 2025, emphasizes the importance of talent over rare earth elements in the pharmaceutical industry. He expresses concern about research in Germany and urges political action to address the issue.

Summarized from the sources above. Read the originals for the full story.